Coffee is one of the world's most popular drinks. It is only an inspirational morning refreshment for some, but for others it has become a lifestyle beverage with a global consumption of billions cups per day. Because of its popularity, coffee has often been proposed to be able to prevent health problems and has attracted a great deal of research over the years. Although there has been limited research evaluating the effectiveness of coffee in ameliorating certain health conditions, there is a compelling evidence that coffee consumption has potential benefits for a variety of chronic diseases. Recent studies have confirmed that moderate amount of coffee consumption might have a role in protection against type 2 diabetes, metabolic syndrome, Parkinson's disease, Alzheimer's disease, depression, cognitive impairment, chronic liver disease, chronic kidney disease, prostate cancer, endometrial cancer, liver cancer, leukemia and cardiovascular diseases, including hypertension, coronary heart disease and venous thromboembolism. In dermatological point of view, currently there is a growing body of evidence suggesting that caffeine and other nutrients contained in coffee may protect against melanoma and non-melanoma skin cancer. Moreover, as the new data on coffee and health continues to get emerged, it is getting clear that coffee is also effective in inflammatory disease prevention, including inflammatory skin diseases. In this review, we focused on recent evidence about coffee and dermatological diseases and aimed to explore the link between coffee and melanoma/ non-melanoma skin cancers, psoriasis and rosacea.
Keywords: Coffee; melanoma; non-melanoma skin cancer; psoriasis; rosacea
Kahve dünyada en fazla tüketilen içecekler arasında yer alır. Kahve bazıları için sadece bir sabah uyaranı olabilir, ancak bazıları içinse günlük global tüketimi milyarlarla ölçülen bir hayat tarzı içeceğidir. Popularitesi nedeniyle, kahvenin sıklıkla sağlık problemlerini önlediği ileri sürülmüş ve kahve yıllar içerisinde çok sayıda araştırmanın başlıca konularından biri olmuştur. Her ne kadar, kahvenin bazı hastalıkları iyileştirmesindeki etkinliği ile ilgili ortaya konmuş yeterli veri yoksa da, günümüzde kahvenin çok sayıda kronik hastalığın önlenmesinde faydalı olduğunu gösteren kayda değer veriler bulunmaktadır. Son yıllarda yapılan çalışmalar, makul düzeyde kahve tüketiminin tip 2 diyabet, metabolik sendrom, Parkinson hastalığı, Alzheimer hastalığı, depresyon, kognitif bozukluklar, kronik karaciğer hastalığı, kronik böbrek hastalığı, prostat kanseri, endometrium kanseri, karaciğer kanseri, lösemi ve hipertansiyon, koroner arter hastalığı ve venöz tromboembolizmi de içeren kardiyovasküler hastalıklara karşı koruyucu rol oynayabileceğini göstermiştir. Dermatolojik açıdansa, kahvede bulunan kafein ve diğer bileşenlerin melanoma ve melanom dışı deri kanserlerine karşı koruyucu olduğunu gösteren veriler gün geçtikçe artmaktadır. Dahası, kahve ve sağlıkla ilgili yeni veriler ortaya çıktıkça, kahvenin inflamatuar deri hastalıkları da dahil olmak üzere, inflamatuar hastalıkların önlenmesinde etkili olduğu daha anlaşılır düzeye ulaşmış bulunmaktadır. Bu derlemede, kahve ve deri hastalıkları ile ilgili güncel literatüre odaklandık ve kahve ile melanom, melanom dışı deri kanseri, psöriazis ve rozaseanın ilişkisini irdelemeyi hedefledik.
Anahtar Kelimeler: Kahve; melanom; melanom dışı deri kanseri; psöriazis; rozasea
- Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024. [Crossref]
- Whayne TF Jr. Coffee: a selected overview of beneficial or harmful effects on the cardiovascular system? Curr Vasc Pharmacol. 2015;13(5):63748. [Crossref]
- Fredholm BB. Notes on the history of caffeine use. Handb Exp Pharmacol. 2011;1(200):1-9. [Crossref] [PubMed]
- Loftfield E, Freedman ND, Dodd KW, Vogtmann E, Xiao Q, Sinha R, et al. Coffee drinking is widespread in the United States, but usual intake varies by key demographicand lifestyle factors. J Nutr. 2016;146(9):1762-8. [Crossref] [PubMed] [PMC]
- Weisse AB. Coffee: grounds for concern? Proc (Bayl Univ Med Cent). 2015;28(1):122-3. [Crossref]
- Bae JH, Park JH, Im SS, Song DK. Coffee and health. Integr Med Res. 2014;3(4):189-91. [Crossref] [PubMed] [PMC]
- Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131-56. [Crossref] [PubMed]
- Cano-Marquina A, Tarín JJ, Cano A. The impact of coffee on health. Maturitas. 2013;75(1):7-21. [Crossref] [PubMed]
- Nieber K. The impact of coffee on health. Planta Med. 2017;83(16):1256-63. [Crossref] [PubMed]
- Alicandro G, Tavani A, La Vecchia C. Coffee and cancer risk: a summary overview. Eur J Cancer Prev. 2017;26(5):424-32. [Crossref] [PubMed]
- Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. The safety of ingested caffeine: a comprehensive review. Front Psychiatry. 2017;8(1):80. [Crossref] [PubMed] [PMC]
- Franco R, Oñatibia-Astibia A, Martínez-Pinilla E. Health benefits of methylxanthines in cacao and chocolate. Nutrients. 2013;5(10):4159-73. [Crossref] [PubMed] [PMC]
- Spaeth AM, Goel N, Dinges DF. Cumulative neurobehavioral and physiological effects of chronic caffeine intake: individual differences and implications for the use of caffeinated energy products. Nutr Rev. 2014;72 Suppl 1:34-47. [Crossref]
- Caini S, Cattaruzza MS, Bendinelli B, Tosti G, Masala G, Gnagnarella P, et al. Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis. Eur J Nutr. 2017;56(1):1-12. [Crossref] [PubMed]
- Wu S, Han J, Song F, Cho E, Gao X, Hunter DJ, et al. Caffeine intake, coffee consumption, and risk of cutaneous malignant melanoma. Epidemi ology. 2015;26(6):898-908. [Crossref] [PubMed] [PMC]
- Lukic M, Jareid M, Weiderpass E, Braaten T. Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study. BMC Cancer. 2016;16:562. [Crossref] [PubMed] [PMC]
- Conney AH, Lu YP, Lou YR, Kawasumi M, Nghiem P. Mechanisms of caffeine-induced inhibition of UVB carcinogenesis. Front Oncol. 2013;3:144. [Crossref] [PubMed] [PMC]
- Loftfield E, Freedman ND, Graubard BI, Hollenbeck AR, Shebl FM, Mayne ST, et al. Coffee drinking and cutaneous melanoma risk in the NIHAARP diet and health study. J Natl Cancer Inst. 2015;107(2). [Crossref]
- Liu J, Shen B, Shi M, Cai J. Higher caffeinated coffee intake is associated with reduced malignant melanoma risk: a meta-analysis study. PLoS One. 2016;11(1):e0147056. [Crossref]
- Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study. Eur J Cancer Prev. 2014;23(4):296-302. [Crossref] [PubMed] [PMC]
- Song F, Qureshi AA, Han J. Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res. 2012;72(13):3282-9. [Crossref] [PubMed]
- Oh CC, Jin A, Yuan JM, Koh WP. Coffee, tea, caffeine, and risk of non-melanoma skin cancer in a Chinese population: The Singapore Chinese Health Study. J Am Acad Dermatol. 2019 Feb 4. [Epub ahead of print]. [Crossref]
- Micek A, Godos J, Lafranconi A, Marranzano M, Pajak A. Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies. Int J Food Sci Nutr. 2018;69(4):417-26. [Crossref] [PubMed]
- Wang J, Li X, Zhang D. Coffee consumption and the risk of cutaneous melanoma: a meta-analysis. Eur J Nutr. 2016;55(4):1317-29. [Crossref] [PubMed]
- Vaseghi G, Haghjoo-Javanmard S, Naderi J, Eshraghi A, Mahdavi M, Mansourian M. Coffee consumption and risk of nonmelanoma skin cancer: a dose-response meta-analysis. Eur J Cancer Prev. 2018;27(2):164-70. [Crossref] [PubMed]
- Fortes C, Mastroeni S, Boffetta P, Antonelli G, Pilla MA, Bottà G, et al. The protective effect of coffee consumption on cutaneous melanoma risk and the role of GSTM1 and GSTT1 polymorphisms. Cancer Causes Control. 2013;24(10):1779-87. [Crossref] [PubMed]
- Kang NJ, Lee KW, Shin BJ, Jung SK, Hwang MK, Bode AM, et al. Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase ac tivity and UVB-induced COX-2 expression. Carcinogenesis. 2009;30(2):321-30. [Crossref] [PubMed] [PMC]
- Wang Y, Ho CT. Polyphenolic chemistry of tea and coffee: a century of progress. J Agric Food Chem. 2009;57(18):8109-14. [Crossref] [PubMed]
- Yamagata K. Do coffee polyphenols have a preventive action on metabolic syndrome associated endothelial dysfunctions? An assessment of the current evidence. Antioxidants (Basel). 2018;7(2). [Crossref]
- Andújar I, Recio MC, Giner RM, Ríos JL. Cocoa polyphenols and their potential benefits for human health. Oxid Med Cell Longev. 2012;2012:906252. [Crossref] [PubMed] [PMC]
- Działo M, Mierziak J, Korzun U, Preisner M, Szopa J, Kulma A. The potential of plant phenolics in prevention and therapy of skin disorders. Int J Mol Sci. 2016;17(2):160. [Crossref] [PubMed] [PMC]
- Barrea L, Muscogiuri G, Di Somma C, Annunziata G, Megna M, Falco A, et al. Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff? Arch Toxicol. 2018;92(5):1831-45. [Crossref] [PubMed]
- Sharif K, Watad A, Bragazzi NL, Adawi M, Amital H, Shoenfeld Y. Coffee and autoimmunity: more than a mere hot beverage! Autoimmun Rev. 2017;16(7):712-21. [Crossref]
- Clatici VG, Satolli F, Tatu AL, Voicu C, Draganita AMV, Lotti T. Butterfly effect-the concept and the ımplications in dermatology, acne, and rosacea. Maedica (Buchar). 2018;13(2):89-94.
- Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2-11. [Crossref] [PubMed] [PMC]
- Yuan X, Huang X, Wang B, Huang YX, Zhang YY, Tang Y, et al. Relationship between rosacea and dietary factors: a multicenter retrospective casecontrol survey. J Dermatol. 2019;46(3):219-25. [Crossref] [PubMed]
- Li S, Chen ML, Drucker AM, Cho E, Geng H, Qureshi AA, et al. Association of caffeine intake and caffeinated coffee consumption with risk of incident rosacea in women. JAMA Dermatol. 2018;154(12):1394-400. [Crossref] [PubMed]
- Echeverri D, Montes FR, Cabrera M, Galán A, Prieto A. Caffeine?s vascular mechanisms of action. Int J Vasc Med. 2010;2010(1):834060. [Crossref]
- Schwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):53-62. [Crossref] [PubMed] [PMC]
- Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36(2):81-6. [Crossref] [PubMed]
.: İşlem Listesi